Navigation Links
Ferring Pharmaceuticals Unveils Six-Month Efficacy Data for EUFLEXXA(R) for the Treatment of Osteoarthritis Knee Pain
Date:5/13/2009

euticals, a privately owned, international pharmaceutical company. Ferring Pharmaceuticals offers a line of infertility, urology, and orthopaedic products in the U.S. market. They include: BRAVELLE(R) (urofollitropin for injection, purified), MENOPUR(R) and REPRONEX(R) (menotropins for injection, USP), Novarel(R) (chorionic gonadotropin for injection, USP), ENDOMETRIN(R) (progesterone) Vaginal Insert, 100 mg, PROSED(R) DS (methenamine, phenyl salicylate, methylene blue, benzoic acid, hyoscyamine sulfate), DESMOPRESSIN, DEGARELIX for injection and EUFLEXXA(R) (1% sodium hyaluronate).

Ferring Pharmaceuticals specializes in the research, development and commercialization of compounds in general and pediatric endocrinology, urology, orthopaedics, gastroenterology, obstetrics/gynecology, and infertility. For complete prescribing information, call 1-888-FERRING (1-888-337-7464) or visit www.FerringUSA.com.

* Derived through bacterial fermentation

(1) Data on File, Ferring Pharmaceuticals

(2) Altman RD, Rosen JE. Six-month safety and efficacy of non-avian intra-articular hyaluronan in knee osteoarthritis (OA).

(3) Schiavinato A, Finesso M, Cortivo R, & Abatangelo G (2002). Comparison of the effects of intra-articular injections of Hyaluronan and its chemically cross-linked derivative (Hylan G-F20) in normal rabbit knee joints. Clin Exp Rheumatol 20, 445-454.

(4) Goomer RS, Leslie K, Maris T, & Amiel D (2005). Native hyaluronan produces less hypersensitivity than cross-linked hyaluronan. Clin Orthop Relat Res 239-245.


'/>"/>
SOURCE Ferring Pharmaceuticals Inc.
Copyright©2009 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3

Related medicine technology :

1. deCODE and Radboud University Discover Common Variants in the Human Genome Conferring Risk of Bladder Cancer
2. Ferring Pharmaceuticals Launches Phase IIIB Trial of Degarelix as Intermittent Therapy
3. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
4. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
5. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
6. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
7. WallSt.net (www.wallst.net) Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
8. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
9. Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India
10. Nabi Biopharmaceuticals Announces Second Quarter 2007 Financial Results
11. Access Pharmaceuticals Provides Update on Clinical Development Plan of ProLindac
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/16/2013)... MECHELEN, Belgium , May 17, 2013 /PRNewswire/ ... ABBV ) announced today an extension of their ... will fund and complete a Phase 2 program in ... into Phase 3.  Upon successful completion of the study, ... million.  The terms of the collaboration extension are in ...
(Date:5/16/2013)... 16, 2013  Nektar Therapeutics, (Nasdaq: NKTR ) ... , is scheduled to present at the upcoming 2013 ... at the Sheraton New York Hotel on Tuesday, May ... presentation will be accessible via a Webcast through a link ... Nektar website: http://www.nektar.com . This Webcast will be available ...
(Date:5/16/2013)... FRAMINGHAM, Mass. and SYDNEY , ... HTWR - ASX: HIN), a leading innovator of less ... of advanced heart failure, today announced that CEO ... 2013 UBS Global Healthcare Conference at 11:00 a.m. EDT on ... 20-22, 2013 at the Sheraton New York Hotel. ...
Breaking Medicine Technology:AbbVie and Galapagos Extend GLPG0634 Collaboration to Include Crohn's Disease 2AbbVie and Galapagos Extend GLPG0634 Collaboration to Include Crohn's Disease 3AbbVie and Galapagos Extend GLPG0634 Collaboration to Include Crohn's Disease 4AbbVie and Galapagos Extend GLPG0634 Collaboration to Include Crohn's Disease 5AbbVie and Galapagos Extend GLPG0634 Collaboration to Include Crohn's Disease 6Nektar Therapeutics' President and CEO, Howard W. Robin, To Present at the 2013 UBS Global Healthcare Conference in New York City 2HeartWare Presentation At The 2013 UBS Global Healthcare Conference To Be Webcast 2
(Date:5/18/2013)... 18, 2013 In a May 14, ... Double Mastectomy After Discovering Cancer Gene,” Fox News reported ... upon learning that she carried a gene that doctors ... cancer and a 50 percent risk of ovarian cancer ... on May 16, 2013 with a blog post entitled ...
(Date:5/18/2013)... (May 18, 2013) A ground-breaking advance in ... according to research presented today at Digestive Disease ... minimal withdrawal time for colonoscopies and exploring safer ... colonoscopy, doctors use a device called a colonoscope ... colorectal cancer allows a doctor to look for ...
(Date:5/18/2013)... York, New York (PRWEB) May 18, 2013 ... Gynecare pelvic mesh products continue to move forward in ... Superior Court, Bernstein Liebhard LLP reports. According to a ... Conference in the Ethicon pelvic mesh litigation will be ... that 2,755 complaints have been filed in the proceeding ...
(Date:5/18/2013)... HealthDay Reporter , , FRIDAY, May 17 (HealthDay News) -- It ... but new research shows that college women are more likely ... than are college men. Much of this difference ... on a weekly basis is much lower for women than ... for men. But, there,s good reason for that difference. Women ...
(Date:5/18/2013)... May 18, 2013 After working diligently for ... SizeItUp formally announced the integration of the fitment specs ... Genesis is set to stun the automobile market with its ... Hyundai Genesis is marked as the latest entry in the ... vehicles lined up for the year 2013. , Aptly ...
Breaking Medicine News(10 mins):Health News:Angelina Jolie – Scarless Breast Augmentation Surgery 2Health News:New colonoscope provides ground-breaking view of colon 2Health News:New colonoscope provides ground-breaking view of colon 3Health News:New colonoscope provides ground-breaking view of colon 4Health News:Transvaginal Mesh Lawsuits: Bernstein Liebhard LLP Notes Upcoming Case Management Conference in New Jersey Ethicon Pelvic Mesh Litigation 2Health News:Transvaginal Mesh Lawsuits: Bernstein Liebhard LLP Notes Upcoming Case Management Conference in New Jersey Ethicon Pelvic Mesh Litigation 3Health News:College Women More Prone to Problem Drinking Than Men: Study 2Health News:College Women More Prone to Problem Drinking Than Men: Study 3Health News:Renowned Rim Fitments Provider SizeItUp Launched Database Integrations for the 2012 Hyundai Genesis 2
... that reducing the levels of vascular endothelial growth factor (VEGF), ... vessel growth, in adult mice causes the death of photoreceptors ... essential to visual function. This finding, published in the November ... chronic use of promising new anti-VEGF drugs such as Lucentis, ...
... Commits to Multi-Million-Dollar Five-Year Program; Inaugural ... the Cure Global Promise Fund(R), LONDON, Nov. ... the,largest breast cancer advocacy organization in the world, ... supporter of breast cancer,charities in Europe, in a ...
... investigators to submit abstracts to present their research ... event dedicated to molecular imaging and nuclear medicineJune ... field of molecular imaging is vital and state-of-the-art," ... represents the society,s more than 17,000 molecular imaging ...
... voters with disabilities expected to vote in,presidential election, ... expected to vote in record numbers on Election ... Disabilities (AAPD), the largest,cross-disability membership organization in the ... are expected to cast their,ballots in the general ...
... osteoporosis management is a crucial element in hip,fracture ... patients who,suffer a hip fracture are referred to ... according to a study published in the,November 2008 ... Surgery,( http://www.ejbjs.org ), an osteoporosis management program ...
... LOS ANGELES, Nov. 3 World Champion athlete ... her debut as a member of the,California Governor,s ... included speaking to the student body of NEW ... active and healthy lifestyles., (Photo: http://www.newscom.com/cgi-bin/prnh/20081103/AQM074 ...
Cached Medicine News:Health News:Anti-VEGF drugs for retinal diseases could have serious side effects, scientists caution 2Health News:Anti-VEGF drugs for retinal diseases could have serious side effects, scientists caution 3Health News:Samsung and Susan G. Komen for the Cure(R) Launch Historic Breast Cancer Alliance 2Health News:Samsung and Susan G. Komen for the Cure(R) Launch Historic Breast Cancer Alliance 3Health News:SNM to showcase the latest research in molecular imaging and nuclear medicine 2Health News:Record Number of Voters with Disabilities Will Head to Polls 2Health News:Treating Osteoporosis After Hip Fracture 2Health News:Treating Osteoporosis After Hip Fracture 3Health News:Laila Ali Debuts as Member of California Governor's Council on Physical Fitness and Sports 2
... The intra-operative MR system ... intra-operative tool for radiologists ... goal of the system ... valuable adjunct to standard ...
... By combining intra-operative ultrasound ... Medtronic Surgical Navigation Technologies ... product called SonoNav Intra-operative ... built on the high ...
... two-component fibrin sealant vapor heated ... commercially available fibrin sealant in ... are used for two specific ... to seal tissue. Both of ...
... With Plasmaseal's Proteus device the two ... blood is injected into Proteus' single use ... action base unit. The operator touches a ... plasma is separated by centrifugation. Then the ...
Medicine Products: